Why Monitoring Eye Pressure Could Improve Glaucoma Detection
Have you ever visited an eye clinic, completed a vision examination and been told that your eye pressure appears normal, only to experience concerns about your eyesight later? For people at risk of glaucoma, a single measurement may not always reveal the full picture of what is happening inside their eyes.
Glaucoma is a group of eye diseases that damage the optic nerve, which carries visual information from the eyes to the brain. Because the condition can progress without noticeable symptoms during its early stages, researchers are exploring ways to make monitoring eye pressure more informative and convenient.
On October 22, 2026, Pittwire, the University of Pittsburgh’s official news publication, reported on a research project led by Piervincenzo Rizzo, a professor of civil and environmental engineering at the university’s Swanson School of Engineering. With a $403,633 grant from the National Eye Institute (NEI), part of the National Institutes of Health (NIH), Rizzo and his team are developing a portable device designed to assess properties of the eye that may help with glaucoma monitoring.
Why One Eye Pressure Reading May Not Tell the Whole Story
Eye pressure, medically known as intraocular pressure (IOP), is an important factor in glaucoma assessment. It reflects the pressure created by fluid inside the eye, and elevated pressure can increase the risk of optic nerve damage.
Eye pressure naturally fluctuates throughout the day. A measurement taken during a morning appointment, for example, may differ from the pressure recorded several hours later.
This variation can complicate the assessment of certain patients. Someone may have pressure within the usual range during a clinic visit but experience higher readings at other times, potentially making an important part of their glaucoma risk more difficult to identify.
Traditional tonometry measures intraocular pressure using instruments that may gently contact the eye or use a puff of air, depending on the method. These measurements remain important in eye care, but repeated readings may be necessary when clinicians suspect that pressure changes are contributing to disease progression.
The University of Pittsburgh project aims to explore a different approach: using signals generated by a small mechanical device to evaluate the eye’s physical properties. The long-term goal is to make repeated measurements easier to perform beyond a specialist’s examination room.
How Does the Experimental Glaucoma Device Work?
Rizzo’s engineering background includes nondestructive evaluation and structural health monitoring. These fields involve examining materials and structures for changes or weaknesses without damaging them, and his team is applying related principles to a medical problem.
The experimental instrument contains several small metal spheres arranged inside a tube. A sphere is raised and released, creating a mechanical wave that travels through the arrangement and reaches the patient’s closed eyelid.
The signal then returns toward a sensor, which records the resulting waveform. Algorithms developed by the research team analyse the signal to estimate properties related to the density of the eye.
The underlying principle is similar to observing how a ball rebounds from different surfaces. The way a surface responds to an impact can provide information about its physical characteristics, and the researchers are investigating whether a similar method can provide useful information about the eye.
The approach differs from conventional tonometry, which measures intraocular pressure directly through established measurement techniques. The new device assesses a mechanical response and related eye properties, so its ability to estimate pressure or improve glaucoma assessment must be established through further testing.
From a Large Engineering Structure to an Eye-Sized Instrument
Developing a device small enough for practical medical use has required collaboration across engineering disciplines. Rizzo enlisted Samuel Dickerson, a professor of electrical and computer engineering at the Swanson School of Engineering, to help miniaturise the electronics and develop algorithms for processing the returning signals.
The researchers had previously explored the underlying concept using a much larger structure. Their current prototype has been reduced to approximately the size of an eyeball, making it more suitable for further development as a portable instrument.
According to the October 22 report in Pittwire, the team tested the technology using a synthetic eyeball filled with water to simulate pressure. The initial experiment produced encouraging results, supporting the next stage of the research.
However, success with a simulated eye does not establish that the device can reliably measure eye pressure or detect glaucoma in people. Human eyes vary in their physical characteristics, and researchers will need to determine whether the signals are consistent, interpretable and clinically useful.
What the NIH Grant Will Help Researchers Investigate
The $403,633 award from the National Eye Institute will support the development of a more complete instrument that can be evaluated using real human eyes. The next steps include making the prototype portable and investigating whether its signals can be collected and analysed in a clinical research setting.
The team plans to work with Ian Conner, division chief of the glaucoma and cataract service at UPMC Vision Institute and an associate professor of ophthalmology at the University of Pittsburgh School of Medicine.
Conner’s clinical experience is relevant because some patients show signs of glaucoma progression even when their recorded eye pressure appears normal. In selected cases, clinicians may need repeated measurements over an extended period to identify pressure elevations that a single reading could miss.
The report describes situations in which monitoring can involve hourly measurements over a 12-hour day. A portable instrument that patients could use several times throughout the day might eventually offer a more convenient way to collect additional information.
The proposed device is intended to be portable, relatively inexpensive and simple enough for repeated use without requiring a trained specialist to operate it at every measurement. These are development goals, however, rather than established features of a clinically available product.
Could This Technology Change Glaucoma Monitoring?
If future studies demonstrate that the instrument produces reliable and clinically meaningful results, it could potentially complement existing methods of monitoring eye health. More frequent measurements may help clinicians understand variations that occur between appointments and decide whether additional assessment is needed.
For patients, convenient home monitoring could eventually reduce some of the practical difficulties associated with repeated clinic visits. It might also help researchers investigate how changes in eye pressure relate to glaucoma progression in different individuals.
Nevertheless, the device is still experimental. The initial testing described by the University of Pittsburgh involved a synthetic eye, and the next stage is to evaluate the technology using human eyes with a more fully developed instrument.
Further research will be needed to establish measurement accuracy, repeatability, safety, usability and the relationship between its readings and accepted clinical measurements. Researchers must also determine how well the technology performs across people with different eye characteristics and stages of glaucoma.
The device should therefore not be considered a replacement for comprehensive eye examinations, established tonometry or specialist assessment. Nor does the current research establish that it can diagnose glaucoma independently.
Understanding Glaucoma and Its Risk Factors
Glaucoma can damage the optic nerve gradually, often affecting peripheral vision before central vision becomes noticeably impaired. Many people do not recognise early changes because the brain can compensate for some gradual losses in the visual field.
Risk factors include increasing age, a family history of glaucoma, elevated intraocular pressure and certain medical or eye conditions. Some people develop glaucoma even when their eye pressure is not elevated, which is why clinicians consider more than one measurement when assessing the disease.
Eye care professionals may use tonometry, optic nerve examination, optical coherence tomography (OCT) and visual field testing to evaluate patients. Gonioscopy may also be performed to examine the drainage angle inside the eye and help determine the type of glaucoma.
These assessments provide different kinds of information. No single test necessarily tells the whole story, and the appropriate evaluation depends on the individual’s symptoms, medical history and examination findings.
When Should You See an Eye Doctor?
Do not wait for obvious vision loss before arranging an eye examination if you have a family history of glaucoma, elevated eye pressure or other recognised risk factors. Ask an optometrist or ophthalmologist how frequently you should be examined based on your individual circumstances.
Seek urgent medical attention if you develop sudden severe eye pain, redness, blurred vision, coloured halos around lights, headache, nausea or vomiting. These symptoms may indicate acute angle-closure glaucoma or another eye emergency requiring immediate evaluation.
What Patients Should Do While Research Continues
The University of Pittsburgh research offers a promising example of how engineering can contribute to eye health. By investigating a portable method of assessing eye properties, Rizzo and his collaborators hope to address limitations associated with measurements taken at isolated points during the day.
Still, the $403,633 NEI grant supports the development and investigation of an experimental device, not the launch of an approved glaucoma test. Its potential clinical value will depend on the results of future research involving human eyes.
For now, the most practical step is to schedule regular comprehensive eye examinations, follow your clinician’s monitoring recommendations and report any changes in vision promptly. If you already receive glaucoma treatment, continue following your prescribed care plan while asking your eye specialist whether additional monitoring is appropriate for you.
